Reagents News and Research

RSS

TradeShow Talks with SERVA Electrophoresis

SERVA offers complete packages comprising of device, reagents and qualification from one source accompanying users in a long-term relationship to keep quality as best as possible.

From SERVA Electrophoresis GmbH 12 Apr 2018

TradeShow Talks with Cyanagen

We are Cyanagen, an Italian company, here at Analytica in hall A3 booth 416. We produce reagents for molecular biology, mainly ECL substrates for Western blot analyzers and fluorescent reagents for several applications.

From Cyanagen Srl 12 Apr 2018

Oxford Gene Technology announces leadership changes

Oxford Gene Technology, The Molecular Genetics Company, has announced that on 1st April 2018 Dr John Anson who has been with the company since 2006 as EVP of R&D took over as CEO from Dr Mike Evans, who has become a non-executive director of OGT’s board.

From Oxford Gene Technology 10 Apr 2018

New blood test accurately predicts development of TB two years before onset

A new blood test has been found to more accurately predict the development of tuberculosis up to two years before its onset in people living with someone with active TB, according to research published online in the American Journal of Respiratory and Critical Care Medicine, an American Thoracic Society journal.

6 Apr 2018

Vitl Life Science Solutions announces launch of new Lu-mini at analytica 2018

Vitl Life Science Solutions, a member of the ITL Group, announce the highly-anticipated launch of the Lu-mini – a new product set to revolutionize the market for low-cost OEM benchtop luminometers.

19 Mar 2018

Transformative new approach for viral titer determination using xCELLigence RTCA

Accurate determination of viral titers is critical to vaccine development. Historically, titers have been determined using endpoint assays which are labor-intensive, expensive, and time-consuming. This is increasingly problematic in modern production facilities where bioprocess optimization is performed using high-throughput cell culture reactors that can produce batches of virus faster than they can be analyzed.

13 Mar 2018

The Neuro and Thermo Fisher Scientific team up to accelerate understanding of neurological disease

The Montreal Neurological Institute of McGill University, a world-leading institution focused on brain research and advanced patient care, and Thermo Fisher Scientific, the world leader in serving science, today announce an agreement designed to accelerate the understanding of neurological disease by focusing on about 30 proteins associated with Parkinson's disease, amyotrophic lateral sclerosis (ALS), hereditary spastic paraplegias, epileptic encephalopathies and ataxias, which are all devastating brain diseases.

5 Mar 2018

McGill scientists invent new technique for measuring enzyme inhibition

Researchers at McGill University have invented a new technique for measuring how quickly drugs interact with their molecular targets. The discovery provides scientists with a new way to investigate the effectiveness of drug candidates that might otherwise have been overlooked.

2 Mar 2018

Highly sensitive ELISA method for analysis of CET in plasma samples

This article explores the development, full optimization and validation study of a highly sensitive and selective ELISA for determination of cetuximab (CET) in human plasma samples.

23 Feb 2018

'Click chemistry' approach may improve disease-fighting properties of drugs

Researchers at The Scripps Research Institute have developed a quick and easy way to simultaneously modify dozens of drugs or molecules to improve their disease-fighting properties.

19 Feb 2018

IncuCyte S3 provides real-time around-the-clock live-cell analysis

No matter the time of day or night, see exactly what happened to your cells and when. Biological processes are dynamic, and a single snapshot in time may not capture rare or transient events, causing you to miss a relevant response.

19 Feb 2018

Scientists develop green chemistry method to improve pharmaceutical manufacturing efficiency

About 70 percent of pharmaceuticals are manufactured using palladium-driven catalytic processes that are either fast or efficient - but not both.

14 Feb 2018

Endogenous peptide improves glucose and insulin tolerance and reduces body weight in mice

Treating obese mice with catestatin, a peptide naturally occurring in the body, showed significant improvement in glucose and insulin tolerance and reduced body weight, report University of California San Diego School of Medicine researchers.

7 Feb 2018

Researchers receive major boost to explore long-standing paradigm in endocrinology

A team of researchers at the University of California, Riverside, seeking to upend a long-held theory explaining how hormones freely enter and exit cells, has received a major boost in the form of a $1 million award from the W. M. Keck Foundation.

5 Feb 2018

Metrohm presents accurate method for determination of metal-organic compounds by thermometric titration

Metrohm is pleased to present a fast and highly accurate method for the determination of metal-organic compounds by thermometric titration.

From Metrohm USA Inc. 1 Feb 2018

New family of FFPE reagent kits launched by Beckman Coulter Life Sciences

BCLS launched a family of FormaPure reagent kits for extracting nucleic acid often-challenginging formalin-fixed, paraffin-embedded tissues.

From Beckman Coulter Life Sciences - Automation and Genomics 23 Jan 2018

Why Should We Weigh Every Protein in the Human Body?

Our mission is to advance the measurement of human proteins with greater precision, to bring to the world the benefits of absolute molecular specificity when it comes to interrogating proteins at the molecular level.

From Pittcon 5 Jan 2018

Researchers develop new compound that inhibits growth of melanoma cells

An international team of researchers has developed a novel compound that successfully inhibits growth of melanoma cells by targeting specific epigenetic modifying proteins in these cells.

4 Jan 2018

Leica Biosystems agrees with the UK Office of Life Sciences to advance AI in pathology

A transformative sector deal was announced between companies of the UK life sciences sector and the UK government on Wednesday, December 6th, 2017. This agreement draws substantial investment into the sector including the development of a trail-blazing digital pathology program leveraging Artificial Intelligence.

22 Dec 2017

Salk scientists find simpler way to derive functioning cardiac cells from stem cells

The process by which embryonic stem cells develop into heart cells is a complex process involving the precisely timed activation of several molecular pathways and at least 200 genes.